A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19

por Valencia-Sanchez, Cristina, Wingerchuk, Dean M.
Publicado 2020

Reversible Cerebral Vasculopathy, Transverse Myelitis, and Active Systemic Lupus Erythematosus in an Aquaporin-4 Antibody–Positive Patient

por Gritsch, David, Mbonde, Amir A., Harahsheh, Ehab Y., Chong, Brian W., Wingerchuk, Dean M.
Publicado 2021

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica

por Weinshenker, Brian G., Wingerchuk, Dean M., Pittock, Sean J., Lucchinetti, Claudia F., Lennon, Vanda A.
Publicado 2006

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder

por Berthele, Achim, Levy, Michael, Wingerchuk, Dean M., Pittock, Sean J., Shang, Shulian, Kielhorn, Adrian, Royston, Minying, Sabatella, Guido, Palace, Jacqueline
Publicado 2023

Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews

por Capobianco, Marco, Ringelstein, Marius, Welsh, Carly, Lobo, Patricia, deFiebre, Gabrielle, Lana-Peixoto, Marco, Wang, Jiawei, Min, Ju-Hong, Wingerchuk, Dean M.
Publicado 2023

Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews

por Min, Ju-Hong, Capobianco, Marco, Welsh, Carly, Lobo, Patricia, deFiebre, Gabrielle, Lana-Peixoto, Marco, Wingerchuk, Dean M., Wang, Jiawei, Ringelstein, Marius
Publicado 2023

Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder

por Wingerchuk, Dean M., Zhang, Ina, Kielhorn, Adrian, Royston, Minying, Levy, Michael, Fujihara, Kazuo, Nakashima, Ichiro, Tanvir, Imran, Paul, Friedemann, Pittock, Sean J.
Publicado 2021

A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positiv...

por Wingerchuk, Dean M., Zhang, Ina, Kielhorn, Adrian, Royston, Minying, Levy, Michael, Fujihara, Kazuo, Nakashima, Ichiro, Tanvir, Imran, Paul, Friedemann, Pittock, Sean J.
Publicado 2022

Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension

por Pittock, Sean J, Fujihara, Kazuo, Palace, Jacqueline, Berthele, Achim, Kim, Ho Jin, Oreja-Guevara, Celia, Nakashima, Ichiro, Levy, Michael, Shang, Shulian, Yountz, Marcus, Miller, Larisa, Armstrong, Róisín, Wingerchuk, Dean M
Publicado 2021

Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD

por Wingerchuk, Dean M., Fujihara, Kazuo, Palace, Jacqueline, Berthele, Achim, Levy, Michael, Kim, Ho Jin, Nakashima, Ichiro, Oreja‐Guevara, Celia, Wang, Kai‐Chen, Miller, Larisa, Shang, Shulian, Sabatella, Guido, Yountz, Marcus, Pittock, Sean J.
Publicado 2021

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide

por Hor, Jyh Yung, Asgari, Nasrin, Nakashima, Ichiro, Broadley, Simon A., Leite, M. Isabel, Kissani, Najib, Jacob, Anu, Marignier, Romain, Weinshenker, Brian G., Paul, Friedemann, Pittock, Sean J., Palace, Jacqueline, Wingerchuk, Dean M., Behne, Jacinta M., Yeaman, Michael R., Fujihara, Kazuo
Publicado 2020

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies

por Zhao-Fleming, Hannah H., Valencia Sanchez, Cristina, Sechi, Elia, Inbarasu, Jery, Wijdicks, Eelco F., Pittock, Sean J., Chen, John J., Wingerchuk, Dean M., Weinshenker, Brian G., Lopez-Chiriboga, Sebastian, Dubey, Divyanshu, Tillema, Jan-Mendelt, Toledano, Michel, Yadav, Hemang, Flanagan, Eoin P.
Publicado 2021

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations

por Cree, Bruce AC, Bennett, Jeffrey L, Sheehan, Mark, Cohen, Jeffrey, Hartung, Hans-Peter, Aktas, Orhan, Kim, Ho Jin, Paul, Friedemann, Pittock, Sean, Weinshenker, Brian, Wingerchuk, Dean, Fujihara, Kazuo, Cutter, Gary, Patra, Kaushik, Flor, Armando, Barron, Gerard, Madani, Soraya, Ratchford, John N, Katz, Eliezer
Publicado 2015

Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders

por Redenbaugh, Vyanka, Montalvo, Mayra, Sechi, Elia, Buciuc, Marina, Fryer, James P., McKeon, Andrew, Lennon, Vanda A., Mills, John R., Weinshenker, Brian G., Wingerchuk, Dean M., Chen, John J., Tariq Bhatti, M., Lopez Chiriboga, A. Sebastian, Pittock, Sean J., Flanagan, Eoin P.
Publicado 2021

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis...

por Aktas, Orhan, Hartung, Hans-Peter, Smith, Michael A, Rees, William A, Fujihara, Kazuo, Paul, Friedemann, Marignier, Romain, Bennett, Jeffrey L, Kim, Ho Jin, Weinshenker, Brian G, Pittock, Sean J, Wingerchuk, Dean M, Cutter, Gary, She, Dewei, Gunsior, Michele, Cimbora, Daniel, Katz, Eliezer, Cree, Bruce A
Publicado 2023

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study

por Bove, Riley, Elsone, Liene, Alvarez, Enrique, Borisow, Nadja, Cortez, Melissa M., Mateen, Farrah J., Mealy, Maureen A., Mutch, Kerry, Tobyne, Sean, Ruprecht, Klemens, Buckle, Guy, Levy, Michael, Wingerchuk, Dean M., Paul, Friedemann, Cross, Anne H., Weinshenker, Brian, Jacob, Anu, Klawiter, Eric C., Chitnis, Tanuja
Publicado 2017

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

por Weinshenker, Brian G, Wingerchuk, Dean M, Green, Ari J, Bennett, Jeffrey L, Kim, Ho Jin, Pittock, Sean J, Fujihara, Kazuo, Paul, Friedemann, Cutter, Gary, Marignier, Romain, Aktas, Orhan, Hartung, Hans-Peter, She, Dewei, Smith, Michael, Rees, William, Patterson, Kristina, Cimbora, Daniel, Katz, Eliezer, Cree, Bruce AC
Publicado 2023

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

por Wingerchuk, Dean M., Banwell, Brenda, Bennett, Jeffrey L., Cabre, Philippe, Carroll, William, Chitnis, Tanuja, de Seze, Jérôme, Fujihara, Kazuo, Greenberg, Benjamin, Jacob, Anu, Jarius, Sven, Lana-Peixoto, Marco, Levy, Michael, Simon, Jack H., Tenembaum, Silvia, Traboulsee, Anthony L., Waters, Patrick, Wellik, Kay E., Weinshenker, Brian G.
Publicado 2015

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD

por Cree, Bruce AC, Bennett, Jeffrey L, Kim, Ho Jin, Weinshenker, Brian G, Pittock, Sean J, Wingerchuk, Dean, Fujihara, Kazuo, Paul, Friedemann, Cutter, Gary R, Marignier, Romain, Green, Ari J, Aktas, Orhan, Hartung, Hans-Peter, Williams, Ian M, Drappa, Jorn, She, Dewei, Cimbora, Daniel, Rees, William, Ratchford, John N, Katz, Eliezer
Publicado 2021

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-control...

por Bennett, Jeffrey L., Aktas, Orhan, Rees, William A., Smith, Michael A., Gunsior, Michele, Yan, Li, She, Dewei, Cimbora, Daniel, Pittock, Sean J., Weinshenker, Brian G., Paul, Friedemann, Marignier, Romain, Wingerchuk, Dean, Cutter, Gary, Green, Ari, Hartung, Hans-Peter, Kim, Ho Jin, Fujihara, Kazuo, Levy, Michael, Katz, Eliezer, Cree, Bruce A.C.
Publicado 2022